These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35770458)

  • 21. Novel viral markers and the prediction of off-treatment relapse in chronic hepatitis B patients: A systematic review.
    Jaroenlapnopparat A; Chayanupatkul M; Tangkijvanich P
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2349-2362. PubMed ID: 33811375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of hepatitis B virus core-related antigen and covalently closed circular DNA levels as markers of hepatitis B virus re-infection after liver transplantation.
    Matsuzaki T; Tatsuki I; Otani M; Akiyama M; Ozawa E; Miuma S; Miyaaki H; Taura N; Hayashi T; Okudaira S; Takatsuki M; Isomoto H; Takeshima F; Eguchi S; Nakao K
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1217-22. PubMed ID: 23432697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent advances in understanding and diagnosing hepatitis B virus infection].
    Fourati S; Pawlotsky JM
    Virologie (Montrouge); 2019 Feb; 23(1):23-34. PubMed ID: 31131827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive biomarkers for chronic hepatitis B virus infection management.
    Charre C; Levrero M; Zoulim F; Scholtès C
    Antiviral Res; 2019 Sep; 169():104553. PubMed ID: 31288041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation.
    Suzuki T; Inoue T; Matsuura K; Kusumoto S; Hagiwara S; Ogawa S; Yagi S; Kaneko A; Fujiwara K; Watanabe T; Aoyagi K; Urata Y; Tamori A; Kataoka H; Tanaka Y
    J Gastroenterol; 2022 Jul; 57(7):486-494. PubMed ID: 35478052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi.
    Baudi I; Inoue T; Tanaka Y
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk.
    Samadi Kochaksaraei G; Congly SE; Matwiy T; Castillo E; Martin SR; Charlton CL; Coffin CS
    Liver Int; 2016 Nov; 36(11):1604-1610. PubMed ID: 27059287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy.
    Mak LY; Cloherty G; Wong DK; Gersch J; Seto WK; Fung J; Yuen MF
    Hepatology; 2021 Jun; 73(6):2167-2179. PubMed ID: 33159329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B.
    Chi XM; Wang XM; Wang ZF; Wu RH; Gao XZ; Xu HQ; Ding YH; Niu JQ
    World J Gastroenterol; 2021 Oct; 27(40):6927-6938. PubMed ID: 34790015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.
    Urabe A; Imamura M; Tsuge M; Kan H; Fujino H; Fukuhara T; Masaki K; Kobayashi T; Ono A; Nakahara T; Kawaoka T; Hiramatsu A; Kawakami Y; Aikata H; Hayes CN; Maki N; Ohdan H; Chayama K
    J Gastroenterol; 2017 Mar; 52(3):366-375. PubMed ID: 27422771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D.
    Maasoumy B; Wiegand SB; Jaroszewicz J; Bremer B; Lehmann P; Deterding K; Taranta A; Manns MP; Wedemeyer H; Glebe D; Cornberg M
    Clin Microbiol Infect; 2015 Jun; 21(6):606.e1-10. PubMed ID: 25700889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
    Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
    J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Biomarkers of Chronic Hepatitis B.
    Mak LY; Seto WK; Fung J; Yuen MF
    Gut Liver; 2019 Nov; 13(6):589-595. PubMed ID: 30919601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New viral biomarkers for Hepatitis B: Are we able to change practice?
    Höner Zu Siederdissen C; Maasoumy B; Cornberg M
    J Viral Hepat; 2018 Nov; 25(11):1226-1235. PubMed ID: 30187603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
    Lim YS
    Clin Mol Hepatol; 2023 Jan; 29(1):118-119. PubMed ID: 36443925
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients.
    Kaneko S; Kurosaki M; Inada K; Kirino S; Hayakawa Y; Yamashita K; Osawa L; Sekiguchi S; Higuchi M; Takaura K; Maeyashiki C; Tamaki N; Yasui Y; Itakura J; Takahashi Y; Tsuchiya K; Nakanishi H; Izumi N
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2943-2951. PubMed ID: 34057248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.
    Chuaypen N; Posuwan N; Payungporn S; Tanaka Y; Shinkai N; Poovorawan Y; Tangkijvanich P
    Liver Int; 2016 Jun; 36(6):827-36. PubMed ID: 26678018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.
    García-López M; Lens S; Pallett LJ; Testoni B; Rodríguez-Tajes S; Mariño Z; Bartres C; García-Pras E; Leonel T; Perpiñán E; Lozano JJ; Rodríguez-Frías F; Koutsoudakis G; Zoulim F; Maini MK; Forns X; Pérez-Del-Pulgar S
    J Hepatol; 2021 May; 74(5):1064-1074. PubMed ID: 33278456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA.
    Chen EQ; Wang ML; Tao YC; Wu DB; Liao J; He M; Tang H
    J Viral Hepat; 2019 May; 26(5):586-595. PubMed ID: 30632235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.